Reshape Lifesciences (NASDAQ: RSLS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Reshape Lifesciences (NASDAQ: RSLS) through any online brokerage.
The latest price target for Reshape Lifesciences (NASDAQ: RSLS) was reported by Alliance Global Partners on Thursday, May 26, 2022. The analyst firm set a price target for 4.65 expecting RSLS to rise to within 12 months (a possible 833.92% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Reshape Lifesciences (NASDAQ: RSLS) is $0.4979 last updated Today at August 9, 2022, 6:53 PM UTC.
There are no upcoming dividends for Reshape Lifesciences.
Reshape Lifesciences’s Q2 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Reshape Lifesciences.
Reshape Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.